Cancer screening utilization by residence and sexual orientation

Lee, Minjee; Jenkins, Wiley D.; Boakye, Eric Adjei

doi:10.1007/s10552-020-01339-4

Cited by 14 publications

(11 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Their study shows that individuals who identify as a sexual minority are significantly less likely to have ever undergone cervical cancer screening in comparison with heterosexual individuals; furthermore, although most individuals who identify as a sexual minority are less likely to undergo screening for cervical cancer, regardless of their racial/ethnic backgrounds, those identifying as both Hispanic and a sexual minority have the lowest odds of ever undergoing cervical cancer screening in comparison with non-Hispanic White heterosexual individuals. The finding that sexual minority status is associated with low rates of cervical cancer screening concurs with other studies [3][4][5][6][7][8][9][10][11][12] and highlights the need to better understand cervical cancer screening practices among individuals who identify as a sexual minority so that we can address this disparity and improve cervical cancer screening in this population.…”

supporting

confidence: 86%

Intersecting identities and cancer screening

Tergas

2022

Cancer

View full text Add to dashboard Cite

show abstract

supporting

confidence: 86%

Intersecting identities and cancer screening

Tergas

2022

Cancer

View full text Add to dashboard Cite

show abstract

“…Screening recommendations are in place to detect premalignant lesions or early‐stage cancers and to decrease disease‐related morbidity and mortality 2 . Evidence in the literature, albeit limited, has suggested that sexual minority (SM) individuals (ie, those whose sexual orientation differs from societal norms, including but not limited to those identifying as gay, lesbian, queer, bisexual, pansexual, and beyond 3 ) may be at increased risk for developing gynecologic cancers while also being less likely to undergo cancer screening 4‐14 …”

Section: Introductionmentioning

confidence: 99%

The intersection of sexual orientation with race and ethnicity in cervical cancer screening

Stenzel

Bustamante

Sarkin

et al. 2022

Cancer

View full text Add to dashboard Cite

BACKGROUND: Cervical cancer screening is recommended for those with a cervix who are 21 to 65 years old, with specific timelines being dependent on individual risk. This study compared rates of ever undergoing Papanicolaou (Pap) testing at the intersection of selfreported sexual minority (SM) status and race/ethnicity. METHODS: Data from the National Health Interview Survey (2015 and were used to examine cervical cancer screening disparities. Natal females without a history of hysterectomy who were 21 to 65 years old and had reported their sexual orientation and Pap testing history were included. Demographic and health characteristics were summarized with descriptive statistics. To adjust for differences in confounding variables between groups, propensity score-based inverse probability of treatment weighting (IPTW) was performed. IPTW-adjusted multivariable logistic regression models estimated odds of ever undergoing a Pap test by sexual orientation alone and with race/ethnicity (non-Hispanic White, non-Hispanic Black, and Hispanic). RESULTS: SM persons (n = 877) had significantly reduced odds of ever undergoing Pap testing (odds ratio, 0.54; 95% confidence interval, 0.42-0.70) in comparison with heterosexual persons (n = 17,760). When the intersection of sexual orientation and race/ethnicity was considered, non-Hispanic White SM participants and Hispanic SM participants had reduced odds of ever undergoing Pap testing in comparison with non-Hispanic White heterosexual participants. No significant differences were observed between non-Hispanic White heterosexual participants and participants of non-Hispanic Black SM or Hispanic heterosexual identities. CONCLUSIONS: SM participants were significantly less likely to have ever undergone a Pap test in comparison with heterosexual participants, with Hispanic SM participants having the lowest uptake. Future studies should further examine the roles of systemic discrimination and other key drivers of these disparities.

show abstract

“…A recent study by Lee, Jenkins, & Adjei Boake in 2020 assessed cancer screening by residence and SO [39]. Their study analyzed a total of 171,790 participants from the 2014 and 2016 Behavioral Risk Factor Surveillance System (BRFSS).…”

Section: Discussionmentioning

confidence: 99%

The association of sexual orientation with prostate, breast, and cervical cancer screening and diagnosis.

Herriges

Pinkhasov

Lehavot

et al. 2021

JCO

View full text Add to dashboard Cite

129 Background: Data on heterogeneity in cancer screening and diagnosis rates among lesbians/gays and bisexuals is lacking. Recent studies showed that lesbians/gays and bisexuals have decreased healthcare utilization compared to heterosexual counterparts and continue to experience discrimination in healthcare. Few studies have examined how sexual orientation impacts cancer screening and prevalence. We, therefore, investigated the association between sexual orientation and prevalent sex-specific cancer including prostate, breast, and cervical cancer. Methods: This was a cross-sectional survey-based US study, including men and women aged 18+ from the Health Information National Trends Survey (HINTS) database between 2017-2019. The primary endpoint was individual-reported prostate, breast, and cervical cancer screening and prevalence rates among heterosexual and LGB men and women. Multivariable logistic regression analyses assessed association of various covariates with undergoing screening and diagnosis of these cancers. Results: Overall, 4,441 and 6,333 heterosexual men and women, respectively, were compared to 225 and 213 lesbian/gay and bisexual men and women, respectively. Lesbians/gays and bisexuals were younger and less likely to be screened for prostate, breast, and cervical cancer than heterosexuals. A higher proportion of heterosexual women than lesbian and bisexual women were screened for cervical cancer with pap smears (95.36% vs. 90.48% and 86.11%, p = < 0.001) and breast cancer with mammograms (80.74% vs. 63.81% and 45.37%, p = < 0.001). Similarly, a higher proportion of heterosexual men than gay and bisexual men were screened for prostate cancer with PSA blood tests (41.27% vs. 30.53% and 27.58%, p = < 0.001). Conclusions: Lesbians/gays and bisexuals in the US may be less likely to undergo screening of sex-specific prevalent malignancies, including prostate, breast, and cervical cancer. Healthcare professionals should be encouraged to improve cancer screening among lesbians/gays and bisexuals.

show abstract

Cancer screening utilization by residence and sexual orientation

Cited by 14 publications

References 60 publications

Intersecting identities and cancer screening

Intersecting identities and cancer screening

The intersection of sexual orientation with race and ethnicity in cervical cancer screening

The association of sexual orientation with prostate, breast, and cervical cancer screening and diagnosis.

Contact Info

Product

Resources

About